Accelerated Antibody Discovery Targeting the SARS-CoV-2 Spike Protein for COVID-19 Therapeutic Potential
T. E. Mullen, R. Abdullah, J. Boucher, A. S. Brousseau, N. K. Dasuri, N. T. Ditto, A. M. Doucette, C. Emery, J. Gabriel, B. Greamo, K. S. Patil, K. Rothenberger, J. Stolte, C. A. Souders
This study uses two in vivo approaches to rapidly discover antibodies targeting the SARS-CoV-2 spike protein, identifying candidates with distinct epitope binding and blocking activities.
Antibody Therapeutics · Aug 28, 2021Peer-reviewedImmunology